Ticker
VTGNCompany Name
VISTAGEN THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Current Assets | Current Ratio | Current Liabilities |
---|---|---|---|
6/30/2025 | $ 66.72M | 5.98 | $ 11.15M |
3/31/2025 | $ 82.08M | 6.51 | $ 12.61M |
12/31/2024 | $ 89.94M | 9.35 | $ 9.62M |
9/30/2024 | $ 99.95M | 13.29 | $ 7.52M |
6/30/2024 | $ 110.84M | 17.77 | $ 6.24M |
3/31/2024 | $ 120.67M | 23.55 | $ 5.12M |
12/31/2023 | $ 128.11M | 30.76 | $ 4.16M |
9/30/2023 | $ 39.08M | 13.43 | $ 2.91M |
6/30/2023 | $ 11.58M | 2.86 | $ 4.05M |
3/31/2023 | $ 17.51M | 3.83 | $ 4.57M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
AssetsC / LiabilitesC
(=) Current Ratio
Current Ratio for VISTAGEN THERAPEUTICS INC is calculated as follows: AssetsC [ $ 15.97M ] / LiabilitesC [ $ 3.3M ]
(=) Current Ratio [ 4.84 ]
Minimum
Jun 30, 2023
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 3.2K |
---|---|
min | 0 |
max | 6.79 |
average | 2.02 |
median | 1.62 |
std | 1.44 |